| JYSB2100063 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-02-26 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-12-24 | view |
| JYSB2100062 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-02-26 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-12-24 | view |
| JYSB2000678 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-12-17 | view |
| CYHB2100032 | 托吡酯片 | topiramate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-15 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-11-15 | view |
| CYHB2100030 | 托吡酯片 | topiramate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-15 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-11-15 | view |
| JXSS2100015 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-11-12 | view |
| JXSS2100016 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-11-12 | view |
| JXSS2000050 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-06 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-10-11 | view |
| JYHB2000892 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2020-07-03 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Approval Completed-Pending Certificated | 2021-09-22 | view |
| JYSB2000516 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2020-10-15 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-08-17 | view |
| JYSB2000517 | 乌司奴单抗注射液 | Ustekinumab | Injection | Biological Products | Supplementary Application | 2020-10-15 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-08-17 | view |
| JYSZ2000024 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | License Renew | 2020-12-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-07-28 | view |
| JYHB2002675 | 阿帕他胺片 | apalutamide | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-12-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-03-16 | view |
| CYHB2009094 | 酮康唑乳膏 | ketoconazole | Cream | Chemical Drugs | Supplementary Application | 2020-11-14 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-02-18 | view |
| JYHB2100139 | 阿帕他胺片 | apalutamide | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-02-11 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | In Review | 2021-02-11 | view |
| JYHB2100131 | 盐酸哌甲酯缓释片 | methylphenidate hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-06 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | In Review | 2021-02-05 | view |
| JYHB2100130 | 盐酸哌甲酯缓释片 | methylphenidate hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-06 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | In Review | 2021-02-05 | view |
| JYHB2002093 | 盐酸哌甲酯缓释片 | methylphenidate hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-10-21 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-02-02 | view |
| JYHB2002092 | 盐酸哌甲酯缓释片 | methylphenidate hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-10-21 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-02-02 | view |
| JYHB2100103 | 达芦那韦考比司他片 | cobicistat;darunavir | Tablet | Chemical Drugs | Supplementary Application | 2021-01-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | In Review | 2021-01-27 | view |
